05.07 2017
ICANN

ICANN

His Support of Cultural Activities

In 2006, Charles Rosier supported a film produced by a famous Italian screenwriter and director, which won a Silver Lion award at the Venice film festival. He has a passion for culture and music. This is evident in the way he provides support to certain performers and movies. Charles Rosier was able to help a French musician with her debut album in 2012 and did wonderful things for a Silver Lion-winning film in 2006. His support for a famous French female musician was a wonderful example of his huge passion for culture and music.

Charles Rosier invested in MPOWERD, helping the company financially to develop lanterns and other energy solutions. As a result, over 25 poor countries all around the planet have been supplied by MPOWERD. He gave his support to Luci MPOWERD, being the perfect source of clean and renewable-energy. He helped the company to develop solutions that are more innovative. Charles Rosier is dedicated to helping the environment by developing energy and power sectors in poor countries.

Job

Charles Rosier deals with all the French-speaking markets like France, Belgium and Quebec at UBS Warburg. Charles Rosier finally joined BTG Pactual in August 2010. In addition to this, he became a partner there. BTG Pactual is an investment bank situated in Latin America. BTG Pactual employs around 2,500 employees from all areas of Latin America and has been in operation for 30 years.

Charles Rosier earned his first scientific Baccalaureate degree (which is same as A-levels in the UK). He was able to establish his career after obtaining a degree at ESCP Europe. Charles Rosier spent 2 years of extra study in preparation for additional French requirements.

Healthcare Projects of Charles Rosier

The drug project Charles Rosier financed was for the treatment of stroke known to cause spinal cord problems. The Mapreg Drug project was Charles Rosier’s first healthcare project. Because of the capital he provided, the research on depression, strokes and other serious diseases was conducted at Mapreg, a Paris-based laboratory. He helped Baulieu and his co-workers to formulate a new drug by financing the research.